SCHEMBL4938448

SCHEMBL4938448

CCC(C)C(C)C(CC(=O)O)NC(C)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
MME P08473 2/20 0.36
ACE P12821 2/20 0.36
CPA1 P15085 2/20 0.36
ACE2 Q9BYF1 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33
NFKB1 P19838 1/20 0.33
PTGS2 P35354 1/20 0.33
THPO P40225 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
GNPAT O15228 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GZMB P10144 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4938443 1.00 ALDH1A1 (0.37) ALDH1A1MMEACECPA1ACE2
SCHEMBL4940673 0.86 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL4940668 0.86 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2KDM4EMAPTTHRB
SCHEMBL4937972 0.83 GPR84 (0.39) MAPTGNPAT
SCHEMBL4937977 0.83 GPR84 (0.39) MAPTGNPAT
SCHEMBL4014195 0.81 CTSC (0.36) ALDH1A1MMEACECPA1ACE2
SCHEMBL4452755 0.81 MGAM (0.41) ALDH1A1KMT2AALOX15L3MBTL1
SCHEMBL4989784 0.81 MGAM (0.41) ALDH1A1KMT2AALOX15L3MBTL1
SCHEMBL4005337 0.81 CTSC (0.36) ALDH1A1MMEACECPA1ACE2
SCHEMBL6404270 0.81 MGAM (0.41) ALDH1A1KMT2AALOX15L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194841-A1 Preparation of Optically Pure Beta-Amino Acids Having Affinity for the Alpha-Delta Protein PFIZER INC. 2008-08-14 US disclosed
EP-1863780-A1 PREPARATION OF OPTICALLY PURE BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN Pharmacia & Upjohn Company LLC (US) 2007-12-12 EP disclosed
WO-2006100568-A1 PREPARATION OF OPTICALLY PURE BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194841-A1 Preparation of Optically Pure Beta-Amino Acids Having Affinity for the Alpha-Delta Protein OPRD1, CHRND, CHRNE ALDH1A1 2244/4885MME 1926/4885ACE 2864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.